Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 23776 [2019-10740]
Download as PDF
<![CDATA[
23776
Federal Register / Vol. 84, No. 100 / Thursday, May 23, 2019 / Notices
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary
Advisory Panel; Notice of Federal
Advisory Committee Meeting
Under Secretary of Defense for
Personnel and Readiness, Department of
Defense.
ACTION: Notice of Federal Advisory
Committee meeting.
AGENCY:
The Department of Defense
(DoD) is publishing this notice to
announce that the following Federal
Advisory Committee meeting of the
Uniform Formulary Beneficiary
Advisory Panel will take place.
DATES: Open to the public Wednesday,
June 26, 2019, from 9:00 a.m. to 12:00
p.m.
ADDRESSES: The address of the open
meeting is the Naval Heritage Center
Theater, 701 Pennsylvania Avenue NW,
Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT:
Colonel Paul J. Hoerner, USAF, 703–
681–2890 (Voice), None (Facsimile),
dha.ncr.j-6.mbx.baprequests@mail.mil
(Email). Mailing address is 7700
Arlington Boulevard, Suite 5101, Falls
Church, VA 22042–5101. Website:
https://health.mil/bap. The most up-todate changes to the meeting agenda can
be found on the website.
SUPPLEMENTARY INFORMATION: This
meeting is being held under the
provisions of the Federal Advisory
Committee Act (FACA) of 1972 (5
U.S.C., Appendix, as amended), the
Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and
41 CFR 102–3.140 and 102–3.150.
The Panel will review and comment
on recommendations made to the
Director of the Defense Health Agency,
by the Pharmacy and Therapeutics
Committee, regarding the Uniform
Formulary.
Purpose of the Meeting: The
Department of Defense (DoD) is
publishing this notice to announce that
the following Federal Advisory
Committee meeting of the Uniform
Formulary Beneficiary Advisory Panel
will take place.
SUMMARY:
khammond on DSKBBV9HB2PROD with NOTICES
Agenda
1. Sign-In.
2. Welcome and Opening Remarks.
3. Scheduled Therapeutic Class Reviews
(Comments will follow each agenda
item).
a. Proton Pump Inhibitors—Alternate
Dosage Forms.
b. Proton Pump Inhibitors—Capsules and
Tablets.
VerDate Sep<11>2014
16:40 May 22, 2019
Jkt 247001
c. Pulmonary Arterial Hypertension—
Endothelin Receptor Antagonists.
d. Pulmonary Arterial Hypertension—
Prostacyclin Nebulized Therapy.
e. Pulmonary Arterial Hypertension—
Prostacyclin Oral Therapy.
f. Pulmonary Arterial Hypertension—
Soluble Guanylate Cyclase Stimulator.
4. Newly Approved Drugs Review.
5. Pertinent Utilization Management Issues.
6. Panel Discussions and Vote.
Meeting Accessibility: Pursuant to 5
U.S.C. 552b, as amended, and 41 Code
of Federal Regulations (CFR) 102–3.140
through 102–3.165, and the availability
of space, this meeting is open to the
public. Seating is limited and will be
provided only to the first 220 people
signing-in. All persons must sign-in
legibly.
Written Statements: Pursuant to 41
CFR 102–3.140, the public or interested
organizations may submit written
statements to the membership of the
Panel about its mission and/or the
agenda to be addressed in this public
meeting. Written statements should be
submitted to the Panel’s Designated
Federal Officer (DFO). The DFO’s
contact information can be obtained
previously in this announcement.
Written comments or statements must
be received by the committee DFO at
least five (5) business days prior to the
meeting so that they may be made
available to the Panel for its
consideration prior to the meeting. The
DFO will review all submitted written
statements and provide copies to all the
committee members.
Dated: May 17, 2019.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2019–10740 Filed 5–22–19; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID: DOD–2019–OS–0030]
Submission for OMB Review;
Comment Request
Office of the Under Secretary of
Defense for Policy, DoD.
ACTION: 30-Day information collection
notice.
AGENCY:
The Department of Defense
has submitted to OMB for clearance the
following proposal for collection of
information under the provisions of the
Paperwork Reduction Act.
DATES: Consideration will be given to all
comments received by June 24, 2019.
SUMMARY:
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Comments and
recommendations on the proposed
information collection should be
emailed to Ms. Jasmeet Seehra, DoD
Desk Officer, at oira_submission@
omb.eop.gov. Please identify the
proposed information collection by DoD
Desk Officer, Docket ID number, and
title of the information collection.
FOR FURTHER INFORMATION CONTACT:
Angela James, 571–372–7574, or
whs.mc-alex.esd.mbx.dd-dodinformation-collections@mail.mil.
SUPPLEMENTARY INFORMATION:
Title; Associated Form; and OMB
Number: Security Assistance Network
(SAN); OMB Control Number 0704–
0555.
Type of Request: Extension.
Number of Respondents: 1,784.
Responses per Respondent: 1.
Annual Responses: 1,784.
Average Burden per Response: 15
minutes.
Annual Burden Hours: 446.
Needs and Uses: The Security
Assistance Network (SAN) is a web
based database used to exchange
Security Cooperation training
information between overseas Security
Cooperation Offices, Geographical
Combatant Commands, Military
Departments, Defense Security
Cooperation Agency, DoD
Schoolhouses, Regional Centers, and
International Host Nation Organizations.
The Security Cooperation Training
Management System (SC–TMS) is a tool
used by the Security Cooperation
community to manage International
Military Student training data.
Affected Public: Individuals or
households.
Frequency: As required.
Respondent’s Obligation: Voluntary.
OMB Desk Officer: Ms. Jasmeet
Seehra.
You may also submit comments and
recommendations, identified by Docket
ID number and title, by the following
method:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Instructions: All submissions received
must include the agency name, Docket
ID number, and title for this Federal
Register document. The general policy
for comments and other submissions
from members of the public is to make
these submissions available for public
viewing on the internet at https://
www.regulations.gov as they are
received without change, including any
personal identifiers or contact
information.
ADDRESSES:
E:\FR\FM\23MYN1.SGM
23MYN1
]]>Agencies
[Federal Register Volume 84, Number 100 (Thursday, May 23, 2019)]
[Notices]
[Page 23776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10740]
[[Page 23776]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Under Secretary of Defense for Personnel and Readiness,
Department of Defense.
ACTION: Notice of Federal Advisory Committee meeting.
-----------------------------------------------------------------------
SUMMARY: The Department of Defense (DoD) is publishing this notice to
announce that the following Federal Advisory Committee meeting of the
Uniform Formulary Beneficiary Advisory Panel will take place.
DATES: Open to the public Wednesday, June 26, 2019, from 9:00 a.m. to
12:00 p.m.
ADDRESSES: The address of the open meeting is the Naval Heritage
Center Theater, 701 Pennsylvania Avenue NW, Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice), None (Facsimile), [email protected] (Email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://health.mil/bap. The most up-to-date changes to the meeting agenda can
be found on the website.
SUPPLEMENTARY INFORMATION: This meeting is being held under the
provisions of the Federal Advisory Committee Act (FACA) of 1972 (5
U.S.C., Appendix, as amended), the Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
The Panel will review and comment on recommendations made to the
Director of the Defense Health Agency, by the Pharmacy and Therapeutics
Committee, regarding the Uniform Formulary.
Purpose of the Meeting: The Department of Defense (DoD) is
publishing this notice to announce that the following Federal Advisory
Committee meeting of the Uniform Formulary Beneficiary Advisory Panel
will take place.
Agenda
1. Sign-In.
2. Welcome and Opening Remarks.
3. Scheduled Therapeutic Class Reviews (Comments will follow each
agenda item).
a. Proton Pump Inhibitors--Alternate Dosage Forms.
b. Proton Pump Inhibitors--Capsules and Tablets.
c. Pulmonary Arterial Hypertension--Endothelin Receptor
Antagonists.
d. Pulmonary Arterial Hypertension--Prostacyclin Nebulized
Therapy.
e. Pulmonary Arterial Hypertension--Prostacyclin Oral Therapy.
f. Pulmonary Arterial Hypertension--Soluble Guanylate Cyclase
Stimulator.
4. Newly Approved Drugs Review.
5. Pertinent Utilization Management Issues.
6. Panel Discussions and Vote.
Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and
41 Code of Federal Regulations (CFR) 102-3.140 through 102-3.165, and
the availability of space, this meeting is open to the public. Seating
is limited and will be provided only to the first 220 people signing-
in. All persons must sign-in legibly.
Written Statements: Pursuant to 41 CFR 102-3.140, the public or
interested organizations may submit written statements to the
membership of the Panel about its mission and/or the agenda to be
addressed in this public meeting. Written statements should be
submitted to the Panel's Designated Federal Officer (DFO). The DFO's
contact information can be obtained previously in this announcement.
Written comments or statements must be received by the committee DFO at
least five (5) business days prior to the meeting so that they may be
made available to the Panel for its consideration prior to the meeting.
The DFO will review all submitted written statements and provide copies
to all the committee members.
Dated: May 17, 2019.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2019-10740 Filed 5-22-19; 8:45 am]
BILLING CODE 5001-06-P
